OBJECTIVE: We aimed to investigate whether mitochondrial ATP-sensitive potassium (mitoK ATP ) channels play any role on cardiovascular effects of thiopental (TP) or ketamine (K) anesthesia in rats. BACKGROUND: mitoK ATP channels are the end-effectors of cardioprotection induced by some anesthetics. TP and K are the most frequently used anesthetics with their own cardiovascular effects in experimental studies. To the best of our knowledge, there is no study investigating the cardiovascular effects of TP and K associated with mitoK ATP channels. MATERIALS AND METHODS: The experimental groups: TP control, K/Xylazine (X) control, TP+5-hydroxydecanoate (5-HD; mitoK ATP channel blocker) and K/X+5-HD. Mean arterial blood pressure (MABP), heart rate (HR) and standard limb lead II ECG were recorded and arrhythmia parameters were evaluated. RESULTS: Blockage of mitoK ATP channels by 5-HD increased MABP and decreased HR in the TP+5-HD and K/ X+5-HD groups, respectively. 5-HD caused an increase in ventricular ectopic beat (VEB) incidence. Moreover, VEB incidence was signifi cantly different in TP+5-HD (100 %) than K/X+5-HDgroup (66.6 %) and ventricular tachycardia was only seen in TP+5-HD (incidence was 88.3 %). CONCLUSION: mitoK ATP channels play different roles in infl uencing cardiovascular effects of K/X and TP anesthesia in rats. The differences in hemodynamic parameters and arrhythmia scores of these anesthetics should be considered when they are used in an experimental study associated with mitoK ATP channels (Fig. 3, Ref. 35) . Text in PDF www.elis.sk.
Introduction
Anesthesia is an essential part of the surgical process that removes sensory functions temporarily, depresses the nervous system and so causes blackout of consciousness. In experimental animals, anesthetics are being widely used to prevent sensation of fear and pain of animals associated with surgical procedure, protect the researcher and provide safely and an easy surgical approach. The purpose of the experiment, type and duration of the surgical procedure, species of the animal, experience of the researcher are the main factors when choosing the anesthetic. However, anesthetics can effect a great number of organ systems, so choosing the anesthetic has a great impact on the experimental protocol (1) .
Thiopental (TP) is the most frequently used barbiturate as a general anesthetic in experimental animals. Although TP could reduce blood pressure and cardiac contractility, it does not cause severe arrhythmia. So TP is preferred especially in designing experiments associated with cardiovascular system. Ketamine (K) is frequently used as a parenteral dissociative anesthetic without its visceral analgesic effect. Ketamine anesthesia increases heart rate, systemic blood pressure, pulmonary arterial pressure and cardiac output (2) . Xylazine (X), an α 2adrenoceptor agonist, has sedative and analgesic effects but it is not accepted as a general anesthetic. Addition of X to K anesthesia is frequently used to eliminate the undesirable effects (delirium, increase of secretion) of K.
ATP-sensitive potassium (K ATP ) channels were isolated from different tissues, e.g. ventricle myocytes, brain, smooth muscle, skeletal muscle and pancreas. It has been reported that opening of the myocardial K ATP channels is an endogenous protective mechanism against ischemic injury (3) and also mediates protective effects of ischemic-or anesthetic-induced preconditioning (4, 5) . In addition to sarcolemmal K ATP channels, activation of mitochondrial K ATP (mitoK ATP ) channels which are located on mitochondrial inner membrane, is involved as a trigger in ischemic preconditioning/cardio-protection by different subcellular mechanisms (6) . The opening of mitoK ATP channels induces an increase in K + current, that is enough to change the mitochondrial volume without an important depolarization of the membrane (7, 8) . It is suggested that changing the volume of mitochondria has important effects on cell energy coupling. This mild depolarization of the mitochondrial membrane potential by opening mitoK ATP channels also limits mitochondrial Ca 2+ loading by decreasing the driving force for Ca 2+ infl ux (9) . 5-hydroxydecanoate (5-HD) blocks selectively mitoK ATP channels (10) (11) (12) and in this way it may attenuate the ischemic or pharmacological preconditioning of the heart. Although there are some studies which suggest that 5-HD blocks also the sarcolemmal K ATP channels, it is also known that 5-HD is much more potent on mitoK ATP channels (13, 14) .
The mitoK ATP channels are the end-effectors of the cardioprotection of volatile anesthetics (5, 9) . TP and K are the most frequently used anesthetics with their own cardiovascular effects in experimental studies. But there is no study investigating the cardiovascular effects of TP and K associated with mitoK ATP channels. So the aim of the present study was to investigate whether mitoK ATP channels play any role on cardiovascular effects of thiopental (TP) or ketamine (K) anesthesia in rats.
Materials and methods
This study was approved by the Baskent University Ethical Committee for Experimental Research on Animals (DA 10/11). All experiments were performed on male Wistar Albino rats (n = 22, 250-450 g). The rats were housed in cages at room temperature 21 ± 1 °C, under 12/12 hours light/dark cycle and were allowed "ad libitum" access to standard laboratory diet and tap water. In anesthetized animals tracheotomy was performed and they were mechanically ventilated with room air with the help of the animal ventilator (Rodent Ventilator 7025 UgoBasile, 5 mL/100 g, 34 pulse/min room air). Body temperature of the experimental animals was maintained at 37 ± 1 °C. A standard limb lead II electrocardiogram (ECG) and heart rate were continuously monitored and recorded throughout the experiment, using electrocardiograph (ECG 100B; Biopac. System Inc.) and a computerized data acquisition system. After the right jugular vein cannulation, saline (0.8 mL/h) was continually administered during the experiments with an infusion pump (JMS SP-100s). The left carotid artery was cannulated with a heparinized saline fi lled catheter connected to a pressure transducer (MAY GTA200) for arterial blood pressure monitoring. After all the surgical procedures had been performed, related records were monitored and saved during the 10-minute period through MP100 system (Biopac Systems, Inc.). At the end of the experimental protocol, the rats were sacrifi ced with a high dose anesthetic.
The study animals were divided into groups as follows: I. Thiopental control group (TP control, n = 5): Rats were anesthetized with thiopental sodium (75 mg/kg, i.p.) (15) , II. Ketamine/xylazine control group (K/X control, n =5): Rats were anesthetized with ketamine/xylazine (60/10 mg/kg, i.p.) (16) , III. Thiopental+5-hydroxydecanoate group (TP+5-HD, n = 6): 5-hydroxydecanoate (5-HD, 50 ng/g, i.p.) was administered 5 minutes before the thiopental sodium (75 mg/kg, i.p.) anesthesia, IV. Ketamine/xylazine+5-hydroxydecanoate group (K/X+5-HD, n = 6): 5-hydroxydecanoate (5-HD, 50 ng/g, i.p.) was administered 5 minutes before the ketamine/xylazine (60/10 mg/ kg, i.p.) anesthesia.
Statistical analysis
Statistical evaluation was performed by Graph Pad Software. Data are expressed as mean ± S.E.M or the percentage of incidence. For repeated measurements, two-way ANOVA was used in hemodynamic parameters. Incidence of arrhythmia was evaluated by Fisher's exact test, p < 0.05 was considered to indicate statistical signifi cance.
Results
The hemodynamic parameters including mean arterial blood pressure (MABP) and heart rate (HR) were monitored during the 10-minute period for the experimental protocol. MABP and HR were not signifi cantly different in TP control and K/X control groups. However blockage of the mitoK ATP channels by 5-HD, MABP was increased signifi cantly only in TP+5-HD group when compared to its own control group. But there was no signifi cant difference in MABP between K/X+5-HD and its control group (Fig. 1 ). Furthermore, blockage of the mitoK ATP channels by 5-HD caused a decrease in HR only in K/X+5-HD compared with its control group (Fig. 2) .
At the end of the experimental protocol, the arrhythmia parameters were evaluated from ECG records of experiment animals in accordance with the Lambeth conventions (17) . The incidence of ventricular ectopic beat (VEB), ventricular tachycardia (VT) and ventricular fi brillation (VF) were determined in each group. Severe arrhytmogenic effects were evaluated with the mitoK ATP channel blocker (Fig. 3) . Blockage of mitoK ATP channels by 5-HD signifi cantly increased the VEB incidence when compared with their control groups. Moreover, the incidence of VEB in TP+5-HD (100 was signifi cantly different from K/X+5-HD group (66.6 %). During the experimental protocol, VT was not observed in TP control, K/X control and K/X+5-HD groups. But VT was observed in TP+5-HD group with 88.3 %incidence. VF was not observed in any experimental group.
Discussion
It is an important to bear in mind that anesthetics which will be used in experimental studies, especially related with cardiovascular system, may affect hemodynamic parameters and arrhythmia scores differently. One of the reasons of this could be that the anesthetic has different effects associated with different mechanisms (i.e. mitoK ATP channel, oxidative stress). This may explain the inconsistent results in many articles in the literature.
Oxidative stress results from imbalance between oxidants and antioxidants in favor of the oxidants (18) . It causes excessive production of reactive oxygen species (ROS). Indeed, redox signaling has regulatory role on several physiological processes in the heart (i.e. excitation-contraction coupling) (19) . However, excess accumulation of ROS induces a chain of reactions in cardiovascular pathological processes such as hypertension, ischemia/reperfusion injury (20) . It has been reported that markers of oxidative stress (such as malondialdehyde, superoxide dismutase and catalase) are affected by ketamine and thiopental to different degrees (21) .
Mitochondria is the main target and end effector for a number of cellular metabolic processes including cell-signaling cascades, redox control, ion homeostasis and cell death. Mitochondria are important in relation to oxidative stress because it is the main source for pathological ROS production (22) . It has also been known that impaired mitochondrial function is the most important reason of reperfusion injury, e.g. apoptosis, necrosis and cell death (23) . That is why mitochondria is the main target of protective interventions against reperfusion injury. Impairment of cardiac mitochondrial function after ischemia or ischemia/reperfusion causes a decrease in the adenine nucleotide content of myocytes, impairment in the adenine nucleotide translocase activity, depression of the respiratory chain complex activity, attenuation in membrane potential and decrease in NADH dehydrogenase activity (23) (24) (25) (26) (27) (28) . Considering all this energy related changes in reperfusion injury, opening of the mitoK ATP channels seems to be important to protect the heart. It has already been reported that mitoK ATP channels in the heart play an important role in protective effects of preconditioning against ischemia/reperfusion injury (29) (30) (31) . The cardioprotection provided by mitoK ATP channels could be affected by the administered anesthetic in the experimental animal studies.
The present study investigated whether the mitoK ATP channels have any role on cardiovascular effects of TP or K anesthesia in rats. 5-HD, a specifi c mitoK ATP channel blocker, increased MABP only in TP+5-HD group. But 5-HD did not cause any signifi cant change in MABP in K/X+5-HD group. On the other hand, blockage of mitoK ATP channels by 5-HD decreased HR only in K/X+5-HD group. When the arrhythmia parameters were evaluated in TP+5-HD and K/X+5-HD groups, there was an increase in arrhythmia parameters, especially in TP+5-HD group. There were studies about important role of the mitoK ATP channels in antiarrhythmic effects of nicorandil, 3-pyridyl pinacidil or exercise against to I/R injury (32, 33) . Furthermore, it has been demonstrated that increase in mitoK ATP channel activity by diazoxide in isolated rat cardiomyocytes is inhibited by TP and R-ketamine but not by Sketamine or xylazine (34) . The different interaction with mitoK ATP channels and the anesthetic could refl ect hemodynamic parameters.
It has been known that the hemodynamic parameters are closely related with arrhythmia parameters. Thus the severe arrythmogenic effect of TP could be associated with the increase in the MABP when mitoK ATP channels are blocked. In addition to this, it has been reported that decrease in HR could play a cardioprotective role against ischemia/reperfusion injury (35) . Similarly in the present study, 5-HD induced decrease in HR in K/X+5-HD group may cause cardioprotection in arrhythmia scores.
In conclusion, mitoK ATP channels that play important role in cardioprotection have also effects on K and T anesthesia. The present investigation has shown the fi rst time to the best of our knowledge, mitoK ATP channels blockage by 5-HD differently refl ected the hemodynamic parameters and arrhythmia scores dependent on the anesthesia type: K or TP. So, it is one of the important steps to select the right anesthetic for cardiovascular experimental studies, especially for those including mitoK ATP channels because of the different interaction of K or TP with mitoK ATP channels. 
